Pagni BA
NYU Langone Center for Psychedelic Medicine, Department of Psychiatry, NYU Grossman School of Medicine, New York, NY, USA.
ArticlePsilocybin
Human brain changes after first psilocybin use.
PreprintPsilocybin
Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial
ArticlePsilocybin
Exploring serotonergic psychedelics as a treatment for personality disorders.
ArticlePsilocybin
Psilocybin-Assisted Therapy May Enhance Conservation Values in Patients with Alcohol Use Disorder.
ArticleAyahuasca
Long-Term Mental Health and Wellbeing Outcomes Associated with Naturalistic Ayahuasca Consumption.
ArticlePsilocybin
Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial.
ArticlePsilocybin
Psilocybin-induced changes in neural reactivity to alcohol and emotional cues in patients with alcohol use disorder: an fMRI pilot study.
ArticlePsilocybin
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences.
ArticlePsilocybin
Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.
ArticlePsilocybin
Default Mode Network Modulation by Psychedelics: A Systematic Review.
ArticleAyahuasca